Menu

City Therapeutics, Inc. CTY

Full chart Compare
Set alert

Price alert · CTY

All alert types
18.67 USD +0.42 (+2.30%)

At closeNov 9, 2026, 4:00 PM EST

18.67 0.00 0.00%

After hours · Nov 9, 4:00 PM ET

17.88 Day range 18.85
15.81 52-week range 23.88
YTD
-16.65%
1 year
-16.65%

Revenue & Expenses

Other Income → Expenses: $3.67MExpenses → Selling, General & Admin: $15.06MExpenses → Research & Development: $58.42MExpenses → Interest Expense: $2.26MGross Profit → Expenses: $13.56MRevenue → Gross Profit: $13.56MNet Loss → Expenses: $58.51MOther Income$3.67MGross Profit$13.56MNet Loss$58.51MExpenses$75.74MSelling, General & Admin$15.06MResearch & Development$58.42MInterest Expense$2.26MRevenue$13.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

CTY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
13.56M2.78M
13.56M2.78M
13.56M2.78M
73.48M31.87M
58.42M25.68M
15.06M6.19M
-59.92M-29.09M
2.26M448.00K
-58.51M-27.84M
-58.51M-27.84M
-58.51M-27.84M
-58.51M-27.84M
-12.46-8.18
-12.46-8.18
-12.46-8.18
-56.25M-27.39M
-56.25M-27.39M
4.70M3.40M
4.70M3.40M